By preventing this integration step, the virus is effectively neutralized, unable to replicate and establish a productive infection within the host's cellular machinery. After the viral reverse transcriptase converts the single-stranded viral RNA into double-stranded DNA, the virus requires a way to permanently embed this genetic material into the host cell's DNA.
Pharmacology of Integrase Inhibitors Resistance Mechanism Action
Mutations in the integrase gene can alter the binding site, reducing the drug's affinity without completely abolishing the enzyme's function. Integrase inhibitors represent a cornerstone in modern antiretroviral therapy, specifically targeting the HIV lifecycle at a critical juncture.
These molecules function by blocking the action of the viral integrase enzyme, a protein essential for the integration of viral DNA into the genome of the host cell. This class of drugs continues to be a primary focus of research, leading to the development of long-acting injectable formulations and agents with higher genetic barriers to resistance.
Pharmacology of Integrase Inhibitors and Their Resistance Mechanism Action
By coordinating with these metal ions or occupying the space where the viral and host DNA strands meet, the inhibitor effectively sterically hinders the enzymatic activity. This underscores the importance of combination therapy, where integrase inhibitors are used alongside other antiretroviral drugs to suppress viral replication sufficiently to prevent the emergence of resistant strains.
More About Mechanism of action of integrase inhibitors
Looking at Mechanism of action of integrase inhibitors from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Mechanism of action of integrase inhibitors can make the topic easier to follow by connecting earlier points with a few simple takeaways.
